Beijing Wista Pharma Co., Ltd, founded in 2009, is located in Beijing Economic-Technological Development Area, committed to independent research and authorized production for chemical innovative drugs and high-end generic drugs.Our laboratory area is more than 2000 square meters, which has passed the environmental assessment, fire protection and safety assessment in Beijing, is equipped with a series of precise instruments, like, high performance liquid chromatograph, gas chromatograph, ion chromatography...
Our new formulation L-Ornithine-L-Aspartate Infusion for injection( 5gm/10ml ) has been approved by China SFDA on 23th April 2020. The injection registration certificate...
Our new formulation Nafcillin Sodium for injection (1.0gram per ampoule) has been approved by China SFDA on 4th May 2015. The API registration certificate no. is H2015308...
Our new formulation Olopatadine hydrochloride tablets (5mg ) has been approved by China SFDA on 31st May 2022. The tablets registration certificate No. is H20213892 and ...
86-10-67887855
Head Office：5F, Building No.6, HAN's Enterprise Bay, Liangshuihe No.2 Street, Beijing Economic Technological Development Area, Beijing, 100176, P.R.China
Marketing：sales@51cns.com
R&D Department：RD@51cns.com
Wista Pharmam
简体中文
